HepaRegenix

HepaRegenix is a biotech company in Tübingen, Germany, founded in 2017. It has 1 recorded funding round, most recently a Venture Round in April 2025.

Headquarters
Tübingen
Founded
2017
Business Model
B2B
Last Round
Venture RoundApr 2025
Rounds
1

Indexed holds 1 funding round and 6 investors for this company. The full record is or through the API.

About

HepaRegeniX GmbH is a clinical-stage biotechnology company based in Tübingen, Germany, founded in 2017 out of research by Prof. Lars Zender at University Hospital Tübingen together with Prof. Stefan Laufer and Dr. Wolfgang Albrecht. The company develops first-in-class small-molecule MKK4 kinase inhibitors, including lead candidate HRX-215, designed to enhance liver regeneration and treat acute and chronic liver diseases. HepaRegeniX has completed a Phase Ib study of HRX-215 and raised a €21.5 million financing round, backed by investors including Boehringer Ingelheim Venture Fund, High-Tech Gründerfonds, Wellington Partners, and Vesalius Biocapital.

Summary

Its most recent funding was a Venture Round in Apr 2025. Investors include Vesalius Biocapital IV, Novo Holdings A/S and Boehringer Ingelheim Venture Fund.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundApr 2025

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

HepaRegenix on Indexed.vc
<a href="https://indexed.vc/companies/heparegenix"><img src="https://indexed.vc/api/badge/company/heparegenix" alt="HepaRegenix on Indexed.vc" width="260" height="76" /></a>